The Medical Letter on Drugs and Therapeutics
ONLINE
ONLY
ARTICLE
July 22, 2024
View Complete Issue         Table of Contents 2019 
Brella Sweat Control Patch for Primary Axillary Hyperhidrosis (online only)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Brella Sweat Control Patch for Primary Axillary Hyperhidrosis (online only)
July 22, 2024 (Issue: 1707)
Brella Sweat Control Patch (Candesant Biomedical), a sodium-containing transdermal patch, has been cleared by the FDA for in-office treatment of primary axillary hyperhidrosis in adults. It is the first patch to be approved in the US for this...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Brella Sweat Control Patch for Primary Axillary Hyperhidrosis (online only)
Article code: 1707i
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.